A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma
Choo, S.P, Chowbay, B, Ng, Q.S, Thng, C.H, Lim, Cindy, Hartono, S, Koh, T.S, Huynh, H, Poon, D, Ang, M.K, Chang, S, Toh, H.C
Published in European journal of cancer (1990) (01.03.2013)
Published in European journal of cancer (1990) (01.03.2013)
Get full text
Journal Article
Prostate Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality Data
Eala, M.A., Dee, E.C., Jacomina, L.E., Ng, K., Magsanoc, J.M.J., Magsanoc, N.J., DAmico, A.V., Nguyen, P.L., Steinberg, M.L., Toh, H.C., Chua, M.L.K., Kishan, A.U.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
98P Operational challenges of an Asian Pacific (APAC) academic oncology clinical trial
Day, D., Chia, J.W.K., Foo, E.M.J., Ali, R., Toh, H.C., Segelov, E.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
226P LongiBloodImmunoM: A multi-step analysis pipeline for longitudinal blood-based immunomonitoring for immunotherapy clinical trial
Ye, J., Lim, X., Ng, K.S., Kaya, N.A., Lau, M.C., Jia, M., Cheung, C.C.L., Toh, H.C., Choo, S.P., Lee, S.Y., Lee, J.J.X., Liu, J., Lim, T.K.H., Zhai, W., Tai, D.W.M., Yeong, J.P.S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
Day, D., Starus, A., Gebski, V., Simes, J., Hayes, T., Padinharakam, S., Strickland, A.H., Briscoe, K., Varma, S., Barnet, M., Jackson, C., Horvath, L.G., Price, T.J., Tebbutt, N., Karki, B., Diakos, C.I., Chia, J., Toh, H.C., Jones, F.S., Segelov, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial
Chia, J.W.K., Segelov, E., Deng, Y., Wang, W., Ho, G.F., Sharma, A., Ding, K., Chen, G., Jeffery, G.M., Nott, L.M., Zielinski, R., Ahn, J.B., Chao, T-Y., Yau, T., Nabilah, S., Gandhi, M., Rothwell, P., Simes, J., Ali, R., Toh, H.C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)
Toh, H.C., Yang, M-H., Wang, H-M., Hsieh, C-Y., Chitapanarux, I., Ho, K.F., Hong, R-L., Ang, M-K., Colevas, D., Sirachainan, E., Lertbutsayanukul, C., Ho, G.F., Samol, J., Huang, Z., Tan, C., Ding, C., Myo, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
380P Tumour naïve circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
Day, D., Starus, A., Lamik, A., Sieber, O., Begbie, S., Bonaventura, A., Rai, S., Karanth, N., Underhill, C.R., Nott, L.M., van Hazel, G., van Hagen, T., Wong, M., Saqib, A., Eastgate, M., Srivastav, R., Chia, J., Toh, H.C., Jones, F., Segelov, E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Gemcitabine, carboplatin, and Epstein Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized Phase 3 trial
Toh, H.C., Yang, M.-H., Wang, H.-M., Hsieh, C.Y., Chitapanarux, I., Ho, K.F., Hong, R.-L., Ang, M.K., Colevas, A.D., Sirachainan, E., Lertbutsayanukul, C., Ho, G.F., Nadler, E., Algazi, A., Lulla, P., Wirth, L.J., Wirasorn, K., Liu, Y.C., Ang, S.F., Low, S.H.J., Tho, L.M., Hasbullah, H.H., Brenner, M.K., Wang, W.-W., Ong, W.S., Tan, S.H., Horak, I., Ding, C., Myo, A., Samol, J.
Published in Annals of oncology (04.09.2024)
Published in Annals of oncology (04.09.2024)
Get full text
Journal Article
40P YAP1 promotes sorafenib resistance by activation of TGFβ signaling pathway
Chee, C.L., Shuen, W.H. Timothy, Tan, Y.L. Charmaine, Chua, Y.H. Joelle, Liu, X. Adrianna, Koh, L.S., Ba, R., Toh, H.C.
Published in ESMO open (01.10.2023)
Published in ESMO open (01.10.2023)
Get full text
Journal Article
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
Tai, W.M., Yong, W.P., Lim, C., Low, L.S., Tham, C.K., Koh, T.S., Ng, Q.S., Wang, W.W., Wang, L.Z., Hartano, S., Thng, C.H., Huynh, H., Lim, K.T., Toh, H.C., Goh, B.C., Choo, S.P.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
Chia, W.K., Wang, W.-W., Teo, M., Tai, W.M., Lim, W.T., Tan, E.H., Leong, S.S., Sun, L., Chen, J.J., Gottschalk, S., Toh, H.C.
Published in Annals of oncology (01.04.2012)
Published in Annals of oncology (01.04.2012)
Get full text
Journal Article
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
Tai, W.M., Yong, W.P., Lim, C., Low, L.S., Tham, C.K., Koh, T.S., Ng, Q.S., Wang, W.W., Wang, L.Z., Hartono, S., Thng, C.H., Huynh, H., Lim, K.T., Toh, H.C., Goh, B.C., Choo, S.P.
Published in Annals of oncology (01.02.2018)
Published in Annals of oncology (01.02.2018)
Get full text
Journal Article
Validation of Prognostic Value of AJCC 7th Staging System in Patients with Resected Hepatocellular Carcinoma (HCC)
Ang, S.F., Li, H., Choo, S., Tan, I.B., Tan, M.H., Toh, H.C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
Yong, W.P., Goh, B.C., Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article